DOI: 10.1055/s-00000071

Seminars in Neurology


Singer B, Giovannoni G, Hatung H-P, Margolin DH, Kasten L, Cohen JA.
Improvements in quality of life are maintained in alemtuzumab-treated RRMS patients who develop autoimmune adverse events: CARE-MS 2.
Poster presented at: Annual Meeting of the Consortium of Multiple Sclerosis Centers; May 29, 2015; Indianapolis, IN

Download Bibliographical Data

Search in: